Human bHLH transcription factor gene myogenin (MYOG): Genomic sequence and negative mutation analysis in patients with severe congenital myopathies

Genomics

Volumn 57, Issue 3, 1999, Pages 419-423

  Tseng, Brian S ^a   Cavin, Sash T ^a   Hoffman, Eric P ^b   Iannaccone, Susan T ^c   Mancias, Pedro ^a   Booth, Frank W ^a   Butler, Ian J ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN; MYOGENIN; TRANSCRIPTION FACTOR;

ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; MYOPATHY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SKELETAL MUSCLE;

EID: 0033135082     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1998.5719     Document Type: Article

References (19)

1. Anand G., Shapiro D. N., Dickman P. S., Prochownik E. V. Rhabdomyosarcomas do not contain mutations in the DNA binding domains of myogenic transcription factors. J. Clin. Invest. 93:1994;5-9.
2. Braun T., Bober E., Buschhousen D. G., Kohtz S., Brzeschik K. H., Arnold H. H. Differential expression of myogenic determination genes in muscle cells; possible auto-activation by the myf gene products. EMBO J. 8:1989;3617-3625.
3. Brennan T. J., Chakroborty T., Olson E. N. Mutagenesis of the myogenin basic region identifies an ancient protein motif critical for activation of myogenesis. Proc. Natl. Acad. Sci. USA. 88:1991;5675-5679.
4. Chakraborty T., Olson E. N. Domains outside of the DNA-binding domain impart target gene specificity to myogenin and MRF4. Mol. Cell. Biol. 11:1991;6103-6108.
5. Dracopoli N., Haines J., Korf B. Current Protocols in Human Genetics. 1994;Wiley, New York.
6. Engelkamp D., van Heyningen V. Transcription factors in disease. Curr. Opin. Genet. Dev. 6:1996;334-342.
7. Fardeau M., Tome F. M. S. Congenital myopathies. Myology. 1994;McGraw-Hill, New York. p. 1487-1532.
8. Hasty P., Bradley A., Morris J. H., Edmondson D. G., Venuti J. M., Olson E. N., Klein W. H. Muscle deficiency and neonatal death in mice with targeted mutation in the myogenin gene. Nature. 364:1993;501-506.
9. Hoffman E. P. Clinical and histopathological features of abnormalities of the dystrophin-based membrane cytoskeleton. Brain Path. 6:1996;49-61.
10. Iannaccone S.T. Myogenes and myotubes. J. Child Neurol. 7:1992;180-187.
11. Koop B. F., Rowan L., Chen W. Q., Deshpande P., Lee H., Hood L. Sequence length and error analysis of SequenaseR and automated Taq cycle sequencing methods. BioTechniques. 14:1993;442-447.
12. Nabeshima Y., Hanaoka K., Hayasaka M., Esumi E., Li S., Nonaka I., Nabeshima Y. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature. 364:1993;532-535.
13. Olson E. N., Arnold H. H., Rigby P. W. J., Wold B. J. Know your neighbors: Three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell. 85:1996;1-4.
14. Olson E. N., Klein W. H. bHLH factors in muscle development, deadlines and commitments, what to leave in and what to leave out. Genes Dev. 8:1994;1-8.
15. Olson E. N., Edmondson D., Wright W. E., Lin V. K., Guenet J. L., Simon-Chazottes D., Thompson L. H., Stallings R. L., Schroeder W. T., Duvic M., Brock D., Helin D., Siciliano M. J. Myogenin is in an evolutionarily conserved linkage group on human chromosome 1q31-q41 and unlinked to other mapped muscle regulatory factor genes. Genomics. 8:1990;427-434.
16. Salminen A., Braun T., Buchberger A., Jurs S., Winter B., Arnold H. H. Transcription of the muscle regulatory gene Myf4 is regulated by serum components, peptide growth factors and signaling pathways involving G proteins. J. Cell Biol. 115:1991;905-917.
17. Sarnat H. B. New insights into the pathogenesis of congenital myopathies. J. Child Neurol. 9:1994;193-201.
18. Schwartz J. J., Chakroborty T., Martin J., Zhou J., Olson E. N. The basic region of myogenin cooperates with two transcription activation domains to induce muscle-specific transcription. Mol. Cell Biol. 12:1992;266-275.
19. Torres C. F., Moxley R. T. Early predictors of poor outcome in congenital fiber-type disproportion myopathy. Arch. Neurol. 49:1992;855-856.